» Articles » PMID: 18496612

DETERMINING DISEASE CAUSALITY FROM EXPERIMENTAL TOXICOLOGY STUDIES

Overview
Journal J Law Policy
Date 2008 May 23
PMID 18496612
Authors
Affiliations
Soon will be listed here.
References
1.
Preston R . Extrapolations are the Achilles heel of risk assessment. Mutat Res. 2005; 589(3):153-7. DOI: 10.1016/j.mrrev.2005.03.001. View

2.
Haseman J . Statistical support of the proposed National Toxicology Program protocol. Toxicol Pathol. 1983; 11(1):77-82. DOI: 10.1177/019262338301100113. View

3.
Dumitrescu R, Cotarla I . Understanding breast cancer risk -- where do we stand in 2005?. J Cell Mol Med. 2005; 9(1):208-21. PMC: 6741339. DOI: 10.1111/j.1582-4934.2005.tb00350.x. View

4.
Eustis S, Hailey J, Boorman G, Haseman J . The utility of multiple-section sampling in the histopathological evaluation of the kidney for carcinogenicity studies. Toxicol Pathol. 1994; 22(5):457-72. DOI: 10.1177/019262339402200501. View

5.
Tomatis L . Role of experimental and epidemiological evidence of carcinogenicity in the primary prevention of cancer. Ann Ist Super Sanita. 2006; 42(2):113-7. View